The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

The Society of Urologic Oncology (SUO) is recognizing Joseph Smith Jr., M.D., professor of Urologic Surgery, with the Huggins Medal, its highest honor, for his lifetime contributions to the progress in treatment for patients with genitourinary neoplasms, which are tumors or cancer of the reproductive organs and the urinary system.

Beginning this week, Vanderbilt men will have a good excuse to ignore their razors and let their facial hair grow. November has been dubbed “Movember,” a time when men are encouraged to grow a moustache to raise funds and awareness for prostate cancer.

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.

As health care organizations implement new strategies to improve quality and reduce costs, a physician researcher at VUMC is setting out to identify whether there could be unintended effects.

A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival.

Roger Dmochowski, M.D., professor of Urologic Surgery at Vanderbilt University Medical Center, was recently elected a trustee of the American Board of Urology.